SWAN-Venule: An Optimized MRI Technique to Detect the Central Vein Sign in MS Plaques

References

1. 1.↵
   1. Adams CW

   . The onset and progression of the lesion in multiple sclerosis. J Neurol Sci 1975;25:165–82 doi:10.1016/0022-510x(75)90138-0 pmid:1151432

   CrossRefPubMed
2. 2.↵
   1. Tan IL,
   2. van Schijndel RA,
   3. Pouwels PJ, et al

   . MR venography of multiple sclerosis. AJNR Am J Neuroradiol 2000;21:1039–42 pmid:10871010

   Abstract/FREE Full Text
3. 3.↵
   1. Tallantyre EC,
   2. Brookes MJ,
   3. Dixon JE, et al

   . Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology 2008;70:2076–78 doi:10.1212/01.wnl.0000313377.49555.2e pmid:18505982

   FREE Full Text
4. 4.↵
   1. Tallantyre EC,
   2. Morgan PS,
   3. Dixon JE, et al

   . A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions. Invest Radiol 2009;44:491–94 doi:10.1097/RLI.0b013e3181b4c144 pmid:19652606

   CrossRefPubMed
5. 5.↵
   1. Sati P,
   2. Oh J,
   3. Constable RT, et al

   ; NAIMS Cooperative. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol 2016;12:714–22 doi:10.1038/nrneurol.2016.166 pmid:27834394

   CrossRefPubMed
6. 6.↵
   1. Kilsdonk ID,
   2. Lopez-Soriano A,
   3. Kuijer JP, et al

   . Morphological features of MS lesions on FLAIR* at 7T and their relation to patient characteristics. J Neurol 2014;261:1356–64 doi:10.1007/s00415-014-7351-6 pmid:24777693

   CrossRefPubMed
7. 7.↵
   1. Kuchling J,
   2. Ramien C,
   3. Bozin I, et al

   . Identical lesion morphology in primary progressive and relapsing-remitting MS: an ultrahigh field MRI study. Mult Scler 2014;20:1866–71 doi:10.1177/1352458514531084 pmid:24781284

   CrossRefPubMed
8. 8.↵
   1. Cortese R,
   2. Magnollay L,
   3. Tur C, et al

   . Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD. Neurology 2018;90:e1183–90 doi:10.1212/WNL.0000000000005256 pmid:29514948

   Abstract/FREE Full Text
9. 9.↵
   1. Maggi P,
   2. Absinta M,
   3. Grammatico M, et al

   . Central vein sign differentiates multiple sclerosis from central nervous system inflammatory vasculopathies. Ann Neurol 2018;83:283–94 doi:10.1002/ana.25146 pmid:29328521

   CrossRefPubMed
10. 10.↵
    1. Kilsdonk ID,
    2. Wattjes MP,
    3. Lopez-Soriano A, et al

    . Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla. Eur Radiol 2014;24:841–49 doi:10.1007/s00330-013-3080-y pmid:24317461

    CrossRefPubMed
11. 11.↵
    1. Wuerfel J,
    2. Sinnecker T,
    3. Ringelstein EB, et al

    . Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis. Mult Scler 2012;18:1592–99 doi:10.1177/1352458512441270 pmid:22711711

    CrossRefPubMed
12. 12.↵
    1. Sinnecker T,
    2. Clarke MA,
    3. Meier D, et al

    ; MAGNIMS Study Group. Evaluation of the central vein sign as a diagnostic imaging biomarker in multiple sclerosis. JAMA Neurol 2019 Aug 19. [Epub ahead of print] doi:10.1001/jamaneurol.2019.2478] pmid:31424490

    CrossRefPubMed
13. 13.↵
    1. Solomon AJ,
    2. Schindler MK,
    3. Howard DB, et al

    . “Central vessel sign” on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine. Ann Clin Transl Neurol 2016;3:82–87 doi:10.1002/acn3.273 pmid:26900578

    CrossRefPubMed
14. 14.↵
    1. Sati P,
    2. Thomasson DM,
    3. Li N, et al

    . Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis. Mult Scler 2014;20:1464–70 doi:10.1177/1352458514525868 pmid:24639479

    CrossRefPubMed
15. 15.↵
    1. Samaraweera AP,
    2. Clarke MA,
    3. Whitehead A, et al

    . The central vein sign in multiple sclerosis lesions is present irrespective of the T2* sequence at 3 T. J Neuroimaging 2017;27:114–21 doi:10.1111/jon.12367 pmid:27300318

    CrossRefPubMed
16. 16.↵
    1. Dixon JE,
    2. Simpson A,
    3. Mistry N, et al

    . Optimisation of T(2)*-weighted MRI for the detection of small veins in multiple sclerosis at 3 T and 7 T. Eur J Radiol 2013;82:719–27 doi:10.1016/j.ejrad.2011.09.023 pmid:22138119

    CrossRefPubMed
17. 17.↵
    1. Filippi M,
    2. Rocca MA,
    3. Ciccarelli O, et al

    ; MAGNIMS Study Group. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol 2016;15:292–303 doi:10.1016/S1474-4422(15)00393-2 pmid:26822746

    CrossRefPubMed
18. 18.↵
    1. Thompson AJ,
    2. Banwell BL,
    3. Barkhof F, et al

    . Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018;17:162–73 doi:10.1016/S1474-4422(17)30470-2 pmid:29275977

    CrossRefPubMed
19. 19.↵
    1. Solomon AJ,
    2. Bourdette DN,
    3. Cross AH, et al

    . The contemporary spectrum of multiple sclerosis misdiagnosis: a multicenter study. Neurology 2016;87:1393–99 doi:10.1212/WNL.0000000000003152 pmid:27581217

    Abstract/FREE Full Text
20. 20.↵
    1. Maggi P,
    2. Absinta M,
    3. Sati P, et al

    . The “central vein sign” in patients with diagnostic “red flags” for multiple sclerosis: a prospective multicenter 3T study. Mult Scler 2019 Sep 19. [Epub ahead of print] doi:10.1177/1352458519876031 pmid:31536435

    CrossRefPubMed
21. 21.↵
    1. Campion T,
    2. Smith RJ,
    3. Altmann DR, et al

    . FLAIR* to visualize veins in white matter lesions: a new tool for the diagnosis of multiple sclerosis? Eur Radiology 2017;27:4257–63 doi:10.1007/s00330-017-4822-z pmid:28409356

    CrossRefPubMed
22. 22.↵
    1. Wattjes MP,
    2. Rovira A,
    3. Miller D, et al

    ; MAGNIMS study group. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis–establishing disease prognosis and monitoring patients. Nat Rev Neurol 2015;11:597–606 doi:10.1038/nrneurol.2015.157 pmid:26369511

    CrossRefPubMed
23. 23.↵
    1. Rovira A,
    2. Wattjes MP,
    3. Tintore M, et al

    ; MAGNIMS study group. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process. Nat Rev Neurol 2015;11:471–82 doi:10.1038/nrneurol.2015.106 pmid:26149978

    CrossRefPubMed
24. 24.↵
    1. Sati P,
    2. George IC,
    3. Shea CD, et al

    . FLAIR*: a combined MR contrast technique for visualizing white matter lesions and parenchymal veins. Radiology 2012;265:926–32 doi:10.1148/radiol.12120208 pmid:23074257

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Suthiphosuwan S,
    2. Sati P,
    3. Guenette M, et al

    . The central vein sign in radiologically isolated syndrome. AJNR Am J Neuroradiol 2019;40:776–83 doi:10.3174/ajnr.A6045 pmid:31000526

    Abstract/FREE Full Text